申请人:ALNYLAM PHARMACEUTICALS, INC.
公开号:US20160244752A1
公开(公告)日:2016-08-25
The technology described herein relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the Serpina1 gene, and methods of using such dsRNA compositions to inhibit expression of Serpina1.